Nature Communications (Jul 2019)

The tetraspanin CD9 controls migration and proliferation of parietal epithelial cells and glomerular disease progression

  • Hélène Lazareth,
  • Carole Henique,
  • Olivia Lenoir,
  • Victor G. Puelles,
  • Martin Flamant,
  • Guillaume Bollée,
  • Cécile Fligny,
  • Marine Camus,
  • Lea Guyonnet,
  • Corinne Millien,
  • François Gaillard,
  • Anna Chipont,
  • Blaise Robin,
  • Sylvie Fabrega,
  • Neeraj Dhaun,
  • Eric Camerer,
  • Oliver Kretz,
  • Florian Grahammer,
  • Fabian Braun,
  • Tobias B. Huber,
  • Dominique Nochy,
  • Chantal Mandet,
  • Patrick Bruneval,
  • Laurent Mesnard,
  • Eric Thervet,
  • Alexandre Karras,
  • François Le Naour,
  • Eric Rubinstein,
  • Claude Boucheix,
  • Antigoni Alexandrou,
  • Marcus J. Moeller,
  • Cédric Bouzigues,
  • Pierre-Louis Tharaux

DOI
https://doi.org/10.1038/s41467-019-11013-2
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 17

Abstract

Read online

In both focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN), kidney injury is characterised by the invasion of glomerular tufts by parietal epithelial cells (PECs). Here Lazareth et al. identify the tetraspanin CD9 as a key regulator of PEC migration, and find its upregulation in FSGS and CGN contributes to kidney injury in both diseases.